Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy

BACKGROUND: Patients with immunodeficiency diseases require lifelong treatment with immunoglobulin (Ig), yet few studies have vetted dosing strategies and effectiveness of Ig in older patient populations. Patients requiring subcutaneous (SC) Ig (SCIG) typically start with intravenous dosing before t...

Descripción completa

Detalles Bibliográficos
Autores principales: Koterba, Alan P, Stein, Mark R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273447/
https://www.ncbi.nlm.nih.gov/pubmed/25535489
http://dx.doi.org/10.1186/s13223-014-0063-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273447/
https://www.ncbi.nlm.nih.gov/pubmed/25535489
http://dx.doi.org/10.1186/s13223-014-0063-8

Ejemplares similares